PMID- 9416774 OWN - NLM STAT- MEDLINE DCOM- 19980120 LR - 20190701 IS - 0024-3205 (Print) IS - 0024-3205 (Linking) VI - 61 IP - 26 DP - 1997 TI - Brain histamine mediates the bombesin-induced central activation of sympatho-adrenomedullary outflow. PG - 2521-8 AB - Intracerebroventricular (i.c.v.) administration of bombesin (0.3 nmol) increased plasma levels of both adrenaline and noradrenaline in urethane anesthetized rats. These bombesin-induced increases were inhibited by i.c.v. pretreatment with pyrilamine, an H1-receptor antagonist. Ranitidine, an H2-receptor antagonist also inhibited the increase of adrenaline, however, its effective dose was much larger than that of pyrilamine. Furthermore, the bombesin-induced increase of noradrenaline was not effectively inhibited by ranitidine. In the next series, turnover of histamine was assessed by measuring accumulation of tele-methylhistamine (t-MH), a major metabolite of brain histamine. I.c.v. administration of bombesin (0.3-3 nmol) increased turnover of hypothalamic histamine, while its intravenous administration was without effect. The present results suggest that the bombesin-induced central activation of sympatho-adrenomedullary outflow is probably, at least in part, mediated through brain histaminergic neurons. FAU - Okuma, Y AU - Okuma Y AD - Department of Pharmacology, Kochi Medical School, Japan. FAU - Yokotani, K AU - Yokotani K FAU - Murakami, Y AU - Murakami Y FAU - Osumi, Y AU - Osumi Y LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - Netherlands TA - Life Sci JT - Life sciences JID - 0375521 RN - 0 (Histamine H1 Antagonists) RN - 0 (Histamine H2 Antagonists) RN - 820484N8I3 (Histamine) RN - 884KT10YB7 (Ranitidine) RN - 9MV14S8G3E (Pargyline) RN - HPE317O9TL (Pyrilamine) RN - PX9AZU7QPK (Bombesin) RN - X4W3ENH1CV (Norepinephrine) RN - YKH834O4BH (Epinephrine) SB - IM MH - Adrenal Medulla/*drug effects/physiology MH - Animals MH - Bombesin/administration & dosage/*pharmacology MH - Brain/*metabolism MH - Epinephrine/blood MH - Histamine/*physiology MH - Histamine H1 Antagonists/pharmacology MH - Histamine H2 Antagonists/pharmacology MH - Hypothalamus/drug effects/metabolism MH - Injections, Intraventricular MH - Male MH - Norepinephrine/blood MH - Pargyline/pharmacology MH - Pyrilamine/pharmacology MH - Ranitidine/pharmacology MH - Rats MH - Rats, Wistar MH - Sympathetic Nervous System/*drug effects/physiology EDAT- 1997/01/01 00:00 MHDA- 1998/01/07 00:01 CRDT- 1997/01/01 00:00 PHST- 1997/01/01 00:00 [pubmed] PHST- 1998/01/07 00:01 [medline] PHST- 1997/01/01 00:00 [entrez] AID - S0024320597010060 [pii] AID - 10.1016/s0024-3205(97)01006-0 [doi] PST - ppublish SO - Life Sci. 1997;61(26):2521-8. doi: 10.1016/s0024-3205(97)01006-0.